ID   ALKB1_HUMAN             Reviewed;         389 AA.
AC   Q13686; Q8TAU1; Q9ULA7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   28-JUN-2023, entry version 175.
DE   RecName: Full=Nucleic acid dioxygenase ALKBH1 {ECO:0000305};
DE            EC=1.14.11.- {ECO:0000269|PubMed:27497299};
DE   AltName: Full=Alkylated DNA repair protein alkB homolog 1 {ECO:0000303|PubMed:19959401};
DE   AltName: Full=Alpha-ketoglutarate-dependent dioxygenase ABH1 {ECO:0000303|PubMed:19959401};
DE   AltName: Full=DNA 6mA demethylase {ECO:0000250|UniProtKB:P0CB42};
DE   AltName: Full=DNA N6-methyl adenine demethylase ALKBH1 {ECO:0000305};
DE            EC=1.14.11.51 {ECO:0000269|PubMed:30017583};
DE   AltName: Full=DNA lyase ABH1 {ECO:0000303|PubMed:19959401};
DE            EC=4.2.99.18 {ECO:0000305|PubMed:19959401};
DE   AltName: Full=DNA oxidative demethylase ALKBH1;
DE            EC=1.14.11.33 {ECO:0000305|PubMed:18603530};
DE   AltName: Full=mRNA N(3)-methylcytidine demethylase {ECO:0000305};
DE            EC=1.14.11.- {ECO:0000305|PubMed:31188562};
GN   Name=ALKBH1 {ECO:0000312|HGNC:HGNC:17911};
GN   Synonyms=ABH {ECO:0000303|PubMed:17979886}, ABH1
GN   {ECO:0000303|PubMed:19959401}, ALKBH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Synovial sarcoma;
RX   PubMed=8600462; DOI=10.1093/nar/24.5.931;
RA   Wei Y.F., Carter K.C., Wang R.P., Shell B.K.;
RT   "Molecular cloning and functional analysis of a human cDNA encoding an
RT   Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage
RT   repair.";
RL   Nucleic Acids Res. 24:931-937(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17979886; DOI=10.1111/j.1582-4934.2007.00094.x;
RA   Tsujikawa K., Koike K., Kitae K., Shinkawa A., Arima H., Suzuki T.,
RA   Tsuchiya M., Makino Y., Furukawa T., Konishi N., Yamamoto H.;
RT   "Expression and sub-cellular localization of human ABH family molecules.";
RL   J. Cell. Mol. Med. 11:1105-1116(2007).
RN   [5]
RP   FUNCTION, COFACTOR, SUBCELLULAR LOCATION, MUTAGENESIS OF ILE-218; HIS-231;
RP   ASP-233; HIS-287; ARG-338 AND ARG-344, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=18603530; DOI=10.1074/jbc.m803776200;
RA   Westbye M.P., Feyzi E., Aas P.A., Vagbo C.B., Talstad V.A., Kavli B.,
RA   Hagen L., Sundheim O., Akbari M., Liabakk N.B., Slupphaug G., Otterlei M.,
RA   Krokan H.E.;
RT   "Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-
RT   methylcytosine in DNA and RNA.";
RL   J. Biol. Chem. 283:25046-25056(2008).
RN   [6]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF HIS-231; ASP-233 AND HIS-287.
RX   PubMed=19959401; DOI=10.1016/j.dnarep.2009.10.011;
RA   Muller T.A., Meek K., Hausinger R.P.;
RT   "Human AlkB homologue 1 (ABH1) exhibits DNA lyase activity at abasic
RT   sites.";
RL   DNA Repair 9:58-65(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22961808; DOI=10.1002/stem.1228;
RA   Ougland R., Lando D., Jonson I., Dahl J.A., Moen M.N., Nordstrand L.M.,
RA   Rognes T., Lee J.T., Klungland A., Kouzarides T., Larsen E.;
RT   "ALKBH1 is a histone H2A dioxygenase involved in neural differentiation.";
RL   Stem Cells 30:2672-2682(2012).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF LYS-3; LYS-25; LYS-55; LYS-61; LYS-64; LYS-87;
RP   LYS-94; LYS-116; LYS-120; LYS-125; LYS-133; LYS-137; LYS-148; LYS-154;
RP   LYS-158; LYS-167; LYS-182; LYS-183; LYS-241; LYS-335; LYS-362 AND LYS-381.
RX   PubMed=23577621; DOI=10.1042/bj20121908;
RA   Mueller T.A., Andrzejak M.M., Hausinger R.P.;
RT   "A covalent protein-DNA 5'-product adduct is generated following AP lyase
RT   activity of human ALKBH1 (AlkB homologue 1).";
RL   Biochem. J. 452:509-518(2013).
RN   [10]
RP   MUTAGENESIS OF HIS-113; CYS-118; CYS-129; HIS-134; HIS-303; CYS-304;
RP   CYS-371 AND HIS-372.
RX   PubMed=25459764; DOI=10.1016/j.jmgm.2014.10.013;
RA   Silvestrov P., Mueller T.A., Clark K.N., Hausinger R.P., Cisneros G.A.;
RT   "Homology modeling, molecular dynamics, and site-directed mutagenesis study
RT   of AlkB human homolog 1 (ALKBH1).";
RL   J. Mol. Graph. Model. 54:123-130(2014).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 231-HIS--ASP-233.
RX   PubMed=27745969; DOI=10.1016/j.cell.2016.09.038;
RA   Liu F., Clark W., Luo G., Wang X., Fu Y., Wei J., Wang X., Hao Z., Dai Q.,
RA   Zheng G., Ma H., Han D., Evans M., Klungland A., Pan T., He C.;
RT   "ALKBH1-mediated tRNA demethylation regulates translation.";
RL   Cell 167:816-828(2016).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-233 AND ARG-338.
RX   PubMed=27497299; DOI=10.15252/embj.201694885;
RA   Haag S., Sloan K.E., Ranjan N., Warda A.S., Kretschmer J., Blessing C.,
RA   Huebner B., Seikowski J., Dennerlein S., Rehling P., Rodnina M.V.,
RA   Hoebartner C., Bohnsack M.T.;
RT   "NSUN3 and ABH1 modify the wobble position of mt-tRNAMet to expand codon
RT   recognition in mitochondrial translation.";
RL   EMBO J. 35:2104-2119(2016).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=30392959; DOI=10.1016/j.cell.2018.10.006;
RA   Xie Q., Wu T.P., Gimple R.C., Li Z., Prager B.C., Wu Q., Yu Y., Wang P.,
RA   Wang Y., Gorkin D.U., Zhang C., Dowiak A.V., Lin K., Zeng C., Sui Y.,
RA   Kim L.J.Y., Miller T.E., Jiang L., Lee C.H., Huang Z., Fang X., Zhai K.,
RA   Mack S.C., Sander M., Bao S., Kerstetter-Fogle A.E., Sloan A.E., Xiao A.Z.,
RA   Rich J.N.;
RT   "N6-methyladenine DNA modification in glioblastoma.";
RL   Cell 175:1228-1243(2018).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF ASP-233.
RX   PubMed=30017583; DOI=10.1016/j.molcel.2018.06.015;
RA   Xiao C.L., Zhu S., He M., Chen D., Zhang Q., Chen Y., Yu G., Liu J.,
RA   Xie S.Q., Luo F., Liang Z., Wang D.P., Bo X.C., Gu X.F., Wang K., Yan G.R.;
RT   "N6-methyladenine DNA modification in the human genome.";
RL   Mol. Cell 71:306-318(2018).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-233.
RX   PubMed=31188562; DOI=10.1021/acschembio.8b01001;
RA   Ma C.J., Ding J.H., Ye T.T., Yuan B.F., Feng Y.Q.;
RT   "AlkB homologue 1 demethylates N3-methylcytidine in mRNA of mammals.";
RL   ACS Chem. Biol. 14:1418-1425(2019).
CC   -!- FUNCTION: Dioxygenase that acts as on nucleic acids, such as DNA and
CC       tRNA (PubMed:18603530, PubMed:27745969, PubMed:27497299). Requires
CC       molecular oxygen, alpha-ketoglutarate and iron (PubMed:18603530,
CC       PubMed:27497299). A number of activities have been described for this
CC       dioxygenase, but recent results suggest that it mainly acts as on tRNAs
CC       and mediates their demethylation or oxidation depending on the context
CC       and subcellular compartment (PubMed:27745969, PubMed:27497299). Mainly
CC       acts as a tRNA demethylase by removing N(1)-methyladenine from various
CC       tRNAs, with a preference for N(1)-methyladenine at position 58 (m1A58)
CC       present on a stem loop structure of tRNAs (PubMed:27745969). Acts as a
CC       regulator of translation initiation and elongation in response to
CC       glucose deprivation: regulates both translation initiation, by
CC       mediating demethylation of tRNA(Met), and translation elongation, N(1)-
CC       methyladenine-containing tRNAs being preferentially recruited to
CC       polysomes to promote translation elongation (PubMed:27745969). In
CC       mitochondrion, specifically interacts with mt-tRNA(Met) and mediates
CC       oxidation of mt-tRNA(Met) methylated at cytosine(34) to form 5-
CC       formylcytosine (f(5)c) at this position (PubMed:27497299). mt-tRNA(Met)
CC       containing the f(5)c modification at the wobble position enables
CC       recognition of the AUA codon in addition to the AUG codon, expanding
CC       codon recognition in mitochondrial translation (PubMed:27497299).
CC       Specifically demethylates DNA methylated on the 6th position of adenine
CC       (N(6)-methyladenosine) DNA (PubMed:30392959, PubMed:30017583). N(6)-
CC       methyladenosine (m6A) DNA is present at some L1 elements in embryonic
CC       stem cells and probably promotes their silencing (By similarity).
CC       Demethylates mRNAs containing N(3)-methylcytidine modification
CC       (PubMed:31188562). Also able to repair alkylated single-stranded DNA by
CC       oxidative demethylation, but with low activity (PubMed:18603530). Also
CC       has DNA lyase activity and introduces double-stranded breaks at abasic
CC       sites: cleaves both single-stranded DNA and double-stranded DNA at
CC       abasic sites, with the greatest activity towards double-stranded DNA
CC       with two abasic sites (PubMed:19959401). DNA lyase activity does not
CC       require alpha-ketboglutarate and iron and leads to the formation of an
CC       irreversible covalent protein-DNA adduct with the 5' DNA product
CC       (PubMed:19959401, PubMed:23577621). DNA lyase activity is not required
CC       during base excision repair and class switch recombination of the
CC       immunoglobulin heavy chain during B lymphocyte activation. May play a
CC       role in placental trophoblast lineage differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:P0CB42, ECO:0000269|PubMed:18603530,
CC       ECO:0000269|PubMed:19959401, ECO:0000269|PubMed:23577621,
CC       ECO:0000269|PubMed:27497299, ECO:0000269|PubMed:27745969,
CC       ECO:0000269|PubMed:30017583, ECO:0000269|PubMed:30392959,
CC       ECO:0000269|PubMed:31188562}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2'-deoxyribonucleotide-(2'-deoxyribose 5'-phosphate)-2'-
CC         deoxyribonucleotide-DNA = a 3'-end 2'-deoxyribonucleotide-(2,3-
CC         dehydro-2,3-deoxyribose 5'-phosphate)-DNA + a 5'-end 5'-monophospho-
CC         2'-deoxyribonucleoside-DNA + H(+); Xref=Rhea:RHEA:66592, Rhea:RHEA-
CC         COMP:13180, Rhea:RHEA-COMP:16897, Rhea:RHEA-COMP:17067,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:136412, ChEBI:CHEBI:157695,
CC         ChEBI:CHEBI:167181; EC=4.2.99.18;
CC         Evidence={ECO:0000305|PubMed:19959401};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + a methylated nucleobase within DNA + O2 = a
CC         nucleobase within DNA + CO2 + formaldehyde + succinate;
CC         Xref=Rhea:RHEA:30299, Rhea:RHEA-COMP:12192, Rhea:RHEA-COMP:12193,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:16842, ChEBI:CHEBI:30031, ChEBI:CHEBI:32875,
CC         ChEBI:CHEBI:64428; EC=1.14.11.33;
CC         Evidence={ECO:0000305|PubMed:18603530};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + an N(6)-methyl-2'-deoxyadenosine in DNA + O2
CC         = a 2'-deoxyadenosine in DNA + CO2 + formaldehyde + succinate;
CC         Xref=Rhea:RHEA:49524, Rhea:RHEA-COMP:12418, Rhea:RHEA-COMP:12419,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:16842, ChEBI:CHEBI:30031, ChEBI:CHEBI:90615,
CC         ChEBI:CHEBI:90616; EC=1.14.11.51;
CC         Evidence={ECO:0000269|PubMed:30017583, ECO:0000269|PubMed:30392959};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + an N(1)-methyladenosine in tRNA + O2 = an
CC         adenosine in tRNA + CO2 + formaldehyde + succinate;
CC         Xref=Rhea:RHEA:54576, Rhea:RHEA-COMP:10242, Rhea:RHEA-COMP:12312,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:16842, ChEBI:CHEBI:30031, ChEBI:CHEBI:74411,
CC         ChEBI:CHEBI:74491; Evidence={ECO:0000269|PubMed:27745969};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 2-oxoglutarate + 5-methylcytidine(34) in mitochondrial
CC         tRNA(Met) + 2 O2 = 5-formylcytidine(34) in mitochondrial tRNA(Met) +
CC         2 CO2 + H2O + 2 succinate; Xref=Rhea:RHEA:54144, Rhea:RHEA-
CC         COMP:13808, Rhea:RHEA-COMP:13809, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:74483, ChEBI:CHEBI:138075;
CC         Evidence={ECO:0000269|PubMed:27497299};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + an N(3)-methylcytidine in mRNA + O2 = a
CC         cytidine in mRNA + CO2 + formaldehyde + succinate;
CC         Xref=Rhea:RHEA:60920, Rhea:RHEA-COMP:15145, Rhea:RHEA-COMP:15713,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:16842, ChEBI:CHEBI:30031, ChEBI:CHEBI:74894,
CC         ChEBI:CHEBI:82748; Evidence={ECO:0000269|PubMed:31188562};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60921;
CC         Evidence={ECO:0000269|PubMed:31188562};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00805, ECO:0000269|PubMed:18603530,
CC         ECO:0000269|PubMed:30017583};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00805};
CC   -!- SUBUNIT: Monomer (PubMed:19959401). Interacts with DNAJB6 (By
CC       similarity). {ECO:0000250|UniProtKB:P0CB42,
CC       ECO:0000269|PubMed:19959401}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22961808}.
CC       Mitochondrion {ECO:0000269|PubMed:17979886,
CC       ECO:0000269|PubMed:18603530, ECO:0000269|PubMed:27497299}. Note=Mainly
CC       localizes in euchromatin, largely excluded from heterochromatin and
CC       nucleoli (By similarity). {ECO:0000250|UniProtKB:P0CB42}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:17979886,
CC       ECO:0000269|PubMed:18603530}.
CC   -!- SIMILARITY: Belongs to the alkB family. {ECO:0000305}.
CC   -!- CAUTION: The DNA N6-methyl adenine demethylase activity is subject to
CC       discussion. According to a report, biochemical assays do not reveal
CC       clear DNA N6-methyl adenine demethylase activity in vivo
CC       (PubMed:27745969). According to another study, has clear DNA N6-methyl
CC       adenine demethylase activity (PubMed:30017583).
CC       {ECO:0000269|PubMed:27745969, ECO:0000269|PubMed:30017583}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA63047.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X91992; CAA63047.1; ALT_FRAME; mRNA.
DR   EMBL; AC008044; AAF01478.1; -; Genomic_DNA.
DR   EMBL; BC025787; AAH25787.1; -; mRNA.
DR   CCDS; CCDS32127.1; -.
DR   PIR; S64736; S64736.
DR   RefSeq; NP_006011.2; NM_006020.2.
DR   PDB; 6IE2; X-ray; 2.80 A; A/B/C/D/E/F/G/H=1-389.
DR   PDB; 6IE3; X-ray; 1.97 A; A=1-389.
DR   PDBsum; 6IE2; -.
DR   PDBsum; 6IE3; -.
DR   AlphaFoldDB; Q13686; -.
DR   SMR; Q13686; -.
DR   BioGRID; 114372; 5.
DR   IntAct; Q13686; 1.
DR   STRING; 9606.ENSP00000216489; -.
DR   GlyGen; Q13686; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13686; -.
DR   PhosphoSitePlus; Q13686; -.
DR   SwissPalm; Q13686; -.
DR   BioMuta; ALKBH1; -.
DR   EPD; Q13686; -.
DR   jPOST; Q13686; -.
DR   MassIVE; Q13686; -.
DR   MaxQB; Q13686; -.
DR   PaxDb; Q13686; -.
DR   PeptideAtlas; Q13686; -.
DR   ProteomicsDB; 59661; -.
DR   Antibodypedia; 26095; 300 antibodies from 32 providers.
DR   DNASU; 8846; -.
DR   Ensembl; ENST00000216489.8; ENSP00000216489.3; ENSG00000100601.10.
DR   GeneID; 8846; -.
DR   KEGG; hsa:8846; -.
DR   MANE-Select; ENST00000216489.8; ENSP00000216489.3; NM_006020.3; NP_006011.2.
DR   UCSC; uc001xuc.2; human.
DR   AGR; HGNC:17911; -.
DR   CTD; 8846; -.
DR   DisGeNET; 8846; -.
DR   GeneCards; ALKBH1; -.
DR   HGNC; HGNC:17911; ALKBH1.
DR   HPA; ENSG00000100601; Low tissue specificity.
DR   MIM; 605345; gene.
DR   neXtProt; NX_Q13686; -.
DR   OpenTargets; ENSG00000100601; -.
DR   PharmGKB; PA134906996; -.
DR   VEuPathDB; HostDB:ENSG00000100601; -.
DR   eggNOG; KOG2731; Eukaryota.
DR   GeneTree; ENSGT00390000004599; -.
DR   HOGENOM; CLU_029471_2_1_1; -.
DR   InParanoid; Q13686; -.
DR   OMA; YKRRDPP; -.
DR   OrthoDB; 47845at2759; -.
DR   PhylomeDB; Q13686; -.
DR   TreeFam; TF314609; -.
DR   BRENDA; 1.14.11.51; 2681.
DR   PathwayCommons; Q13686; -.
DR   SignaLink; Q13686; -.
DR   BioGRID-ORCS; 8846; 12 hits in 1160 CRISPR screens.
DR   ChiTaRS; ALKBH1; human.
DR   GenomeRNAi; 8846; -.
DR   Pharos; Q13686; Tbio.
DR   PRO; PR:Q13686; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q13686; protein.
DR   Bgee; ENSG00000100601; Expressed in oocyte and 199 other tissues.
DR   ExpressionAtlas; Q13686; baseline and differential.
DR   Genevisible; Q13686; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0000791; C:euchromatin; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016706; F:2-oxoglutarate-dependent dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0042056; F:chemoattractant activity; IEA:Ensembl.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:UniProtKB.
DR   GO; GO:0070579; F:methylcytosine dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0035516; F:oxidative DNA demethylase activity; IDA:UniProtKB.
DR   GO; GO:0035515; F:oxidative RNA demethylase activity; IDA:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IDA:UniProtKB.
DR   GO; GO:1990984; F:tRNA demethylase activity; IDA:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB.
DR   GO; GO:0080111; P:DNA demethylation; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IDA:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0070989; P:oxidative demethylation; IDA:UniProtKB.
DR   GO; GO:0035513; P:oxidative RNA demethylation; IDA:UniProtKB.
DR   GO; GO:0035552; P:oxidative single-stranded DNA demethylation; IBA:GO_Central.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0070129; P:regulation of mitochondrial translation; IMP:UniProtKB.
DR   GO; GO:0006448; P:regulation of translational elongation; IMP:UniProtKB.
DR   GO; GO:0006446; P:regulation of translational initiation; IMP:UniProtKB.
DR   GO; GO:0042245; P:RNA repair; IDA:UniProtKB.
DR   GO; GO:1990983; P:tRNA demethylation; IDA:UniProtKB.
DR   GO; GO:0002101; P:tRNA wobble cytosine modification; IDA:UniProtKB.
DR   Gene3D; 2.60.120.590; Alpha-ketoglutarate-dependent dioxygenase AlkB-like; 1.
DR   InterPro; IPR004574; Alkb.
DR   InterPro; IPR027450; AlkB-like.
DR   InterPro; IPR037151; AlkB-like_sf.
DR   InterPro; IPR005123; Oxoglu/Fe-dep_dioxygenase.
DR   PANTHER; PTHR16557; ALKYLATED DNA REPAIR PROTEIN ALKB-RELATED; 1.
DR   PANTHER; PTHR16557:SF2; NUCLEIC ACID DIOXYGENASE ALKBH1; 1.
DR   Pfam; PF13532; 2OG-FeII_Oxy_2; 1.
DR   SUPFAM; SSF51197; Clavaminate synthase-like; 1.
DR   PROSITE; PS51471; FE2OG_OXY; 1.
DR   TIGRFAMs; TIGR00568; alkb; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Dioxygenase; DNA damage; DNA repair; Iron; Lyase;
KW   Metal-binding; Mitochondrion; Multifunctional enzyme; Nucleus;
KW   Oxidoreductase; Reference proteome; RNA repair; Translation regulation.
FT   CHAIN           1..389
FT                   /note="Nucleic acid dioxygenase ALKBH1"
FT                   /id="PRO_0000066668"
FT   DOMAIN          208..347
FT                   /note="Fe2OG dioxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   REGION          86..389
FT                   /note="tRNA-binding"
FT                   /evidence="ECO:0000305|PubMed:27745969"
FT   BINDING         144
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS38"
FT   BINDING         175..177
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS38"
FT   BINDING         220..222
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q96Q83"
FT   BINDING         231
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805,
FT                   ECO:0000305|PubMed:19959401, ECO:0000305|PubMed:27745969"
FT   BINDING         233
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805,
FT                   ECO:0000305|PubMed:19959401, ECO:0000305|PubMed:27497299,
FT                   ECO:0000305|PubMed:27745969, ECO:0000305|PubMed:31188562"
FT   BINDING         233
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS38"
FT   BINDING         287
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         338..344
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q96Q83"
FT   SITE            133
FT                   /note="Primary catalytic residue forming the imine linkage
FT                   with DNA"
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   SITE            133
FT                   /note="Secondary catalytic residue forming the imine
FT                   linkage with DNA"
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   VARIANT         135
FT                   /note="M -> I (in dbSNP:rs17825440)"
FT                   /id="VAR_048221"
FT   VARIANT         324
FT                   /note="M -> L (in dbSNP:rs6494)"
FT                   /id="VAR_048222"
FT   MUTAGEN         3
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         25
FT                   /note="K->A: Moderate decrease in DNA lyase activity.
FT                   Reduced DNA lyase activity; when associated with A-133."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         55
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         61
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         64
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         87
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         94
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         113
FT                   /note="H->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         116
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         118
FT                   /note="C->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         120
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         125
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         129
FT                   /note="C->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         133
FT                   /note="K->A: Reduced DNA lyase activity. Slightly more
FT                   reduced DNA lyase activity; when associated with A-25.
FT                   Strongly reduced activity; when associated with A-154."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         134
FT                   /note="H->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         137
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         148
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         154
FT                   /note="K->A: Does not affect DNA lyase activity. Strongly
FT                   reduced activity; when associated with A-133."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         158
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         167
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         182
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         183
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         218
FT                   /note="I->L: Reduces Fe2OG dioxygenase activity by 50%."
FT                   /evidence="ECO:0000269|PubMed:18603530"
FT   MUTAGEN         231..233
FT                   /note="HVD->AVA: Loss of catalytic activity. Abolishes
FT                   ability to regulate translation in respose to glucose
FT                   deprivation."
FT                   /evidence="ECO:0000269|PubMed:27745969"
FT   MUTAGEN         231
FT                   /note="H->A: Near loss of Fe2OG dioxygenase activity. No
FT                   effect on DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:18603530,
FT                   ECO:0000269|PubMed:19959401"
FT   MUTAGEN         233
FT                   /note="D->A: Loss of Fe2OG dioxygenase activity. No effect
FT                   on DNA lyase activity. Abolishes ability to mediate
FT                   oxidation of mt-tRNA(Met) methylated at cytosine(34) to
FT                   form 5-formylcytosine (f(5)c). Abolished DNAN6-methyl
FT                   adenine demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:18603530,
FT                   ECO:0000269|PubMed:19959401, ECO:0000269|PubMed:27497299,
FT                   ECO:0000269|PubMed:30017583, ECO:0000269|PubMed:31188562"
FT   MUTAGEN         241
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         287
FT                   /note="H->A: Loss of Fe2OG dioxygenase activity. No effect
FT                   on DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:18603530,
FT                   ECO:0000269|PubMed:19959401"
FT   MUTAGEN         303
FT                   /note="H->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         304
FT                   /note="C->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         335
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         338
FT                   /note="R->A: Reduced Fe2OG dioxygenase activity. Abolishes
FT                   ability to mediate oxidation of mt-tRNA(Met) methylated at
FT                   cytosine(34) to form 5-formylcytosine (f(5)c)."
FT                   /evidence="ECO:0000269|PubMed:18603530,
FT                   ECO:0000269|PubMed:27497299"
FT   MUTAGEN         344
FT                   /note="R->A: Reduced Fe2OG dioxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:18603530"
FT   MUTAGEN         362
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   MUTAGEN         371
FT                   /note="C->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         372
FT                   /note="H->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:25459764"
FT   MUTAGEN         381
FT                   /note="K->A: Does not affect DNA lyase activity."
FT                   /evidence="ECO:0000269|PubMed:23577621"
FT   CONFLICT        133
FT                   /note="K -> T (in Ref. 1; CAA63047)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        266..267
FT                   /note="TA -> PP (in Ref. 1; CAA63047)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="D -> H (in Ref. 3; AAH25787)"
FT                   /evidence="ECO:0000305"
FT   HELIX           22..32
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           57..60
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           69..71
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           74..80
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           85..87
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          99..102
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   TURN            108..110
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           111..120
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   TURN            121..123
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:6IE2"
FT   HELIX           137..140
FT                   /evidence="ECO:0007829|PDB:6IE2"
FT   HELIX           143..152
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           164..167
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          170..175
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   TURN            179..182
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          186..189
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           194..206
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          216..223
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:6IE2"
FT   STRAND          243..250
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          275..278
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           280..284
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          287..292
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:6IE2"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   HELIX           324..334
FT                   /evidence="ECO:0007829|PDB:6IE3"
FT   STRAND          337..344
FT                   /evidence="ECO:0007829|PDB:6IE3"
SQ   SEQUENCE   389 AA;  43832 MW;  539C4CE41D2D8AEC CRC64;
     MGKMAAAVGS VATLATEPGE DAFRKLFRFY RQSRPGTADL EGVIDFSAAH AARGKGPGAQ
     KVIKSQLNVS SVSEQNAYRA GLQPVSKWQA YGLKGYPGFI FIPNPFLPGY QWHWVKQCLK
     LYSQKPNVCN LDKHMSKEET QDLWEQSKEF LRYKEATKRR PRSLLEKLRW VTVGYHYNWD
     SKKYSADHYT PFPSDLGFLS EQVAAACGFE DFRAEAGILN YYRLDSTLGI HVDRSELDHS
     KPLLSFSFGQ SAIFLLGGLQ RDEAPTAMFM HSGDIMIMSG FSRLLNHAVP RVLPNPEGEG
     LPHCLEAPLP AVLPRDSMVE PCSMEDWQVC ASYLKTARVN MTVRQVLATD QNFPLEPIED
     EKRDISTEGF CHLDDQNSEV KRARINPDS
//
